Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Liposomal Doxorubicin|DRUG: Cyclophosphamide|DRUG: Trastuzumab
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Schering-Plough